205 related articles for article (PubMed ID: 35269532)
1. EZH2 and Endometrial Cancer Development: Insights from a Mouse Model.
Fang X; Ni N; Wang X; Tian Y; Ivanov I; Rijnkels M; Bayless KJ; Lydon JP; Li Q
Cells; 2022 Mar; 11(5):. PubMed ID: 35269532
[TBL] [Abstract][Full Text] [Related]
2. Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit Is Required for Uterine Epithelial Integrity.
Fang X; Ni N; Lydon JP; Ivanov I; Bayless KJ; Rijnkels M; Li Q
Am J Pathol; 2019 Jun; 189(6):1212-1225. PubMed ID: 30954472
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines.
Eskander RN; Ji T; Huynh B; Wardeh R; Randall LM; Hoang B
Int J Gynecol Cancer; 2013 Jul; 23(6):997-1005. PubMed ID: 23792601
[TBL] [Abstract][Full Text] [Related]
4. The histone methyltransferase EZH2 is required for normal uterine development and function in mice†.
Nanjappa MK; Mesa AM; Medrano TI; Jefferson WN; DeMayo FJ; Williams CJ; Lydon JP; Levin ER; Cooke PS
Biol Reprod; 2019 Aug; 101(2):306-317. PubMed ID: 31201420
[TBL] [Abstract][Full Text] [Related]
5. Role of EZH2 in Uterine Gland Development.
Ni N; Jalufka FL; Fang X; McCreedy DA; Li Q
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555314
[TBL] [Abstract][Full Text] [Related]
6. Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia.
Chen J; Li J; Han Q; Sun Z; Wang J; Wang S; Zhao RC
Exp Biol Med (Maywood); 2012 Sep; 237(9):1110-6. PubMed ID: 22956625
[TBL] [Abstract][Full Text] [Related]
7. Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice.
Gao Y; Lin P; Lydon JP; Li Q
J Pathol; 2017 Sep; 243(1):89-99. PubMed ID: 28657664
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers.
Navaridas R; Vidal-Sabanés M; Ruiz-Mitjana A; Altés G; Perramon-Güell A; Yeramian A; Egea J; Encinas M; Gatius S; Matias-Guiu X; Dolcet X
Adv Sci (Weinh); 2023 Nov; 10(32):e2303134. PubMed ID: 37749866
[TBL] [Abstract][Full Text] [Related]
9. The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression.
Kim TH; Franco HL; Jung SY; Qin J; Broaddus RR; Lydon JP; Jeong JW
Oncogene; 2010 Jul; 29(26):3770-80. PubMed ID: 20418913
[TBL] [Abstract][Full Text] [Related]
10. The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten.
Liang X; Daikoku T; Terakawa J; Ogawa Y; Joshi AR; Ellenson LH; Sun X; Dey SK
PLoS Genet; 2018 Aug; 14(8):e1007630. PubMed ID: 30142194
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) in high grade endometrial carcinoma.
Zhou J; Roh JW; Bandyopadhyay S; Chen Z; Munkarah AR; Hussein Y; Alosh B; Jazaerly T; Hayek K; Semaan A; Sood AK; Ali-Fehmi R
Gynecol Oncol; 2013 Feb; 128(2):344-8. PubMed ID: 22871469
[TBL] [Abstract][Full Text] [Related]
12. [EZH2 gene silenced by siRNA suppresses the growth and invasion of endometrial carcinoma cells].
Leng L; Huang Q; Dong Y; Yu H; Tian Y; Peng G
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):866-9. PubMed ID: 23803199
[TBL] [Abstract][Full Text] [Related]
13. Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma.
Wang Y; Hou N; Cheng X; Zhang J; Tan X; Zhang C; Tang Y; Teng Y; Yang X
Int J Biol Sci; 2017; 13(5):652-659. PubMed ID: 28539837
[TBL] [Abstract][Full Text] [Related]
14. The noncanonical role of EZH2 in cancer.
Huang J; Gou H; Yao J; Yi K; Jin Z; Matsuoka M; Zhao T
Cancer Sci; 2021 Apr; 112(4):1376-1382. PubMed ID: 33615636
[TBL] [Abstract][Full Text] [Related]
15. Mutual contribution of Pten and estrogen to endometrial carcinogenesis in a PtenloxP/loxP mouse model.
Saito F; Tashiro H; To Y; Ohtake H; Ohba T; Suzuki A; Katabuchi H
Int J Gynecol Cancer; 2011 Nov; 21(8):1343-9. PubMed ID: 21989218
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.
Vo BT; Li C; Morgan MA; Theurillat I; Finkelstein D; Wright S; Hyle J; Smith SMC; Fan Y; Wang YD; Wu G; Orr BA; Northcott PA; Shilatifard A; Sherr CJ; Roussel MF
Cell Rep; 2017 Mar; 18(12):2907-2917. PubMed ID: 28329683
[TBL] [Abstract][Full Text] [Related]
17. Spatial transcriptomics analysis of uterine gene expression in enhancer of zeste homolog 2 conditional knockout mice†.
Mesa AM; Mao J; Medrano TI; Bivens NJ; Jurkevich A; Tuteja G; Cooke PS; Rosenfeld CS
Biol Reprod; 2021 Nov; 105(5):1126-1139. PubMed ID: 34344022
[TBL] [Abstract][Full Text] [Related]
18. Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing.
Jiang FZ; He YY; Wang HH; Zhang HL; Zhang J; Yan XF; Wang XJ; Che Q; Ke JQ; Chen Z; Tong H; Zhang YL; Wang FY; Li YR; Wan XP
Oncotarget; 2015 Dec; 6(42):44660-74. PubMed ID: 26587974
[TBL] [Abstract][Full Text] [Related]
19. A new transgenic mouse model for conditional overexpression of the Polycomb Group protein EZH2.
Koppens MA; Tanger E; Nacerddine K; Westerman B; Song JY; van Lohuizen M
Transgenic Res; 2017 Apr; 26(2):187-196. PubMed ID: 27807665
[TBL] [Abstract][Full Text] [Related]
20. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression.
Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X
Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]